Susquehanna International Group, LLP Adverum Biotechnologies, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.75 - $1.26 $114,876 - $192,991	153,168 Added 358.69%	195,870 $146,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.33 $28,749 - $44,656	19,166 Added 81.43%	42,702 $64,000
Q2 2023 Aug 11, 2023	SELL	$0.68 - $1.59 $40,576 - $94,876	-59,671 Reduced 71.71%	23,536 $37,000
Q1 2023 May 16, 2023	BUY	$0.62 - $0.85 $43,772 - $60,010	70,601 Added 560.06%	83,207 $59,000
Q4 2022 Feb 14, 2023	BUY	$0.54 - $10.3 $6,807 - $129,841	12,606 New	12,606 $7,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $1.34 $58,788 - $97,255	72,579 Added 325.31%	94,890 $113,000
Q4 2021 Feb 14, 2022	BUY	$1.74 - $2.4 $13,215 - $18,228	7,595 Added 51.61%	22,311 $39,000
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $321,724 - $556,830	-154,675 Reduced 91.31%	14,716 $32,000
Q2 2021 Aug 11, 2021	BUY	$3.36 - $10.56 $488,527 - $1.54 Million	145,395 Added 605.91%	169,391 $593,000
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $27,307 - $42,347	2,949 Added 14.01%	23,996 $237,000
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $660,342 - $956,960	-67,108 Reduced 76.13%	21,047 $228,000
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $378,926 - $796,113	36,789 Added 71.62%	88,155 $908,000
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $504,430 - $1.52 Million	-59,136 Reduced 53.52%	51,366 $1.07 Million
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $107,434 - $219,716	13,463 Added 13.87%	110,502 $1.08 Million
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $1.21 Million - $2.88 Million	-235,918 Reduced 70.86%	97,039 $1.12 Million
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $1.57 Million - $4.77 Million	300,073 Added 912.52%	332,957 $1.81 Million
Q2 2019 Aug 16, 2019	BUY	$5.1 - $11.89 $167,708 - $390,990	32,884 New	32,884 $391,000
Q1 2019 May 15, 2019	SELL	$3.03 - $6.02 $48,595 - $96,548	-16,038 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $1.49 Million - $3.07 Million	-518,274 Reduced 97.0%	16,038 $51,000
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $1.44 Million - $3.14 Million	395,372 Added 284.56%	534,312 $3.1 Million
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $395,979 - $548,813	138,940	138,940 $486,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account